Tongling Jyair Bio-Tech Co., Ltd. forecasts that its net profit attributable to shareholders of the listed company for 2025 will be approximately RMB 72 million to RMB 88 million, representing a year-on-year increase of 269.90% to 352.10%. The growth is mainly driven by the increase in orders from overseas customers and the rise in the comprehensive gross profit margin of products.